Wholesale of pharmaceutical and medical goods
LABMO LABORATORIEUTSTYR AS
Revenue 2024
NOK 545,000
Operating profit
NOK 12,000
Equity
NOK 105,000
Incorporated
2024
Share capital
NOK 100,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 545k | |
| Total operating costs | 533k | |
| Operating profit (EBIT) | 12k | |
| Net financial items | −239 | |
| Profit for the year | 10k |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 177k | |
| of which current assets | 177k | |
| Equity | 105k | |
| Total liabilities | 72k |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.